Mitochondrial causes of renal insufficiency and hearing loss  by Ireland, James et al.
2444 Letters to the Editor
ANNICK PIERRAT, E´LISABETH GRAVIER, CLAUDE SAUNDERS,
MARIE-VE´RONIQUE CAIRA, ZAKIA AI¨T-DJAFER,
BERNARD LEGRAS, and JEAN-PIERRE MALLIE
Nancy, France
Correspondence to Jean-Pierre Mallie, Faculty of Medicine, Renal
Physiology, Vandoeuvre Cedex, France.
E-mail: jp.mallie@medicine.uhp-nancy.fr
REFERENCES
1. Pierrat A, Gravier E, Saunders C, et al: Predicting GFR in children
and adults: A comparison of the Cockcroft-Gault, Schwartz, and
Modification of Diet in Renal Disease Formulas. Kidney Int 64:1425–
1436, 2003
2. Legras B. E´le´ments de statistique a` l’usage des e´tudiants en
Me´decine, Paris, Presse Universitaire de Nancy, 1998, pp 223
MTHFR C677T polymorphism
and skin color: The white
man’s blackness
To the Editor: The C677T polymorphism of methyl-
enetetrahydrofolate reductase (MTHFR) gene is linked
to higher homocysteine levels and risk for myocardial in-
farction and stroke. MTHFR catalyzes the reaction, pro-
ducing methyltetrahydrofolate, the active form of folic
acid, in the remethylation of homocysteine to methio-
nine. Hyperhomocysteinemia is a known cardiovascular
risk factor, with effects on gene allelic expression in ure-
mic patients [1, 2].
The frequency of the C677T polymorphism is, in its ho-
mozygous TT form, about 20% and more in whites, and
1% or less in blacks from Africa or the United States
[3]. It has been proposed that a selective advantage in
possessing this variant lies in the capability to conserve
folates for DNA production during times of relative fo-
late deficiency. It is not clear why black people shouldn’t
possess this selective advantage.
A dark skin color has been recently envisioned as a
means through which man protects himself from folate
destruction because folates are highly susceptible to ul-
traviolet A (UVA) ray degradation. Skin color represents
a delicate balance between the need to produce enough
vitamin D and folate conservation, in particular when fo-
lates are scarce [4].
We put forward the hypothesis that in black people,
skin color allows for some vitamin D production, while it
protects from folate degradation, and no reason why the
MTHFR variant should have been favored. White people
instead have evolved in a population of individuals where
the MTHFR TT genotype is favored for folate conserva-
tion. Little sun exposure allows for limited folate degra-
dation, and in times of folate deficiency these individuals
would produce enough folates for DNA synthesis. There-
fore, the MTHFR thermolabile variant would represent
“the white man’s blackness.”
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Mitochondrial causes of renal
insufficiency and hearing loss
To the Editor: A recent paper in Kidney International
by Izzedine et al [1] provided an excellent review of ear
and kidney syndromes. We would like to call attention
to another syndrome that can be associated with hear-
ing loss and renal disease. Mutations in the mitochon-
drial gene MTTL1, which encodes tRNA Leu(URR), can
also cause renal dysfunction and hearing loss. In the most
severe form, mutations in this gene cause MELAS syn-
drome (Mitochondrial myopathy, Encephalopathy, Lac-
tic Acidosis, and Stroke), which is a multisystem disorder
that can present with cerebral vascular accidents, seizures,
hearing loss, cardiomyopathy, diabetes, and nephropathy.
Mutation analysis of MTTL1 in MELAS patients reveals
that 80% have the mutation A3243G, 7.5% have T3271C,
and 7.5% to 10% have A3253G [2].
We have evaluated three unrelated patients with the
MTTL1 A3243G mutation and features of MELAS syn-
drome: a 48-year-old man with a creatinine of 2.0 g/dL
who presented with cardiomyopathy, diabetes, and hear-
ing loss; a 22-year-old woman with an iothalamate clear-
ance of 67 mL/min who presented with cardiomyopathy,
history of a thalamic stroke, an elevated blood lactate, and
progressive hearing loss; and a 28-year-old woman with
an iothalamate clearance of 29 mL/min who presented
with hypertrophic cardiomyopathy, history of a stroke,
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seizures, and an elevated blood lactate with normal
hearing.
The incidence of renal involvement in the MELAS syn-
drome is unknown, and the reported frequency of hearing
loss is 75%. The MTTL1 gene mutations should be con-
sidered in patients presenting with renal insufficiency and
hearing loss.
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Gene expression analysis in
microdissected renal biopsy
To the Editor: Microdissection of renal biopsy may be
necessary to analyze gene expression in glomeruli and
tubulointerstitium [1], but this procedure is delicate be-
cause RNA degradation may occur. The Munich group
[2, 3, 4] recently reported the possibility of microdissect-
ing biopsies stored in RNA later, a commercial RNase
inhibitor. We completely agree that control of RNAase
activity is crucial during microdissection; nevertheless,
we obtained different results that may be worthy of
discussion.
The cortical tissue from five kidney biopsies taken from
sites remote from tumor-bearing tissue was immediately
divided under the stereomicroscope into three randomly
allocated pieces: A and B were stored in RNA later
following the protocol instructions to investigate mi-
crodissection feasibility and evaluate RNA extraction,
respectively; C was kept in saline containing 100 U of
RNAsin at 4◦C. After 1 hour of storing in RNA later,
pieces A were microdissected; but although our experi-
ence includes over 150 renal biopsies, we had trouble sep-
arating glomeruli from the tubulointerstitium. Indeed,
fragments of a homogeneous yellowish color appeared
at the stereomicroscope, glomeruli could be hardly rec-
ognized, and specimens appeared compact and stiff, re-
sembling fixed tissues. On the contrary, from pieces C it
was possible to collect easily 10 to 20 glomeruli each.
We agree with the authors in reference to the quality
(yield and purity) of extracted RNA from the cortical tis-
sue of pieces B. Thus, in our experience storing tissues in
RNA later represents an optimal mean to preserve RNA
from degradation, but does not warrant microdissection
of the biopsy.
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Can error in GFR formulas
explain their poor performance
in transplant patients?
To the Editor: In a recent paper by Mariat et al [1], the
performance of several glomerular filtration rate (GFR)
equations was assessed against inulin clearance in renal
transplant patients. One of the GFR estimate equations
used was the Nankivell formula, which was printed as the
following:
GFR (mL/minute) = 6.7/serum creatinine + 0.25 ×
weight – 0.5 × urea – 0.01 × height2 + 35(25 for woman).
However, on review of Dr. Nankivell’s original article
[2], the original formula derived was:
GFR (mL/minute) = 6.7/creatinine (mmol/L) +
BW(kg)/4 – urea(mmol/L)/2 – 100/height(m)2 + 35 (25
for woman).
If this was not a printing error and this formula was
applied to the data, this may account for the relative de-
creased accuracy of the Nankivell formula when com-
pared with the other GFR calculation equations.
In addition, the Levey formula (Mariat et al [1]) was
printed as:
GFR (mL/minute) = 170 × serum creatinine−0.999 ×
age−0.1× 0.762 (if woman) × 1.180 (if patient is black)
